BRD9 and squamous cell lung carcinoma: has-miR-140-3p downregulates the oncogene BRD9 (bromodomain containing 9) expression in squamous cell lung cancer (SqCLC) and inhibits SqCLC tumorigenesis, thus may become a new inhibitor of SqCLC [23].